Patent Assignment
Reel/Frame 050612/0563
Assignment of Assignor's Interest
Recorded: 2019-10-03
Pages: 3
Assignor
SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Executed: 2019-09-04
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
Methods for Treating Diseases Associated with Abnormal ACVR1 Expression and ACVR1 Inhibitors for Use in the Same
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 3, 2019
From: WARNER, STEVEN L.; BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050612/0260 →
Assignment of Assignor's Interest
Oct 3, 2019
From: ARIKAWA, YUKA
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 050612/0386 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0344 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0663 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →